To investigate whether CAF-derived CCL5 mediates the protective effect of tumor cells against cisplatin treatment, we first co-cultured tumor cells with a conditioned medium obtained from CAFs and tested the cells’ response to cisplatin treatment (Fig. 3A). Here, CCL5 is linked to neoplasm.